The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Platelet Lysate Market Research Report 2025

Global Human Platelet Lysate Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1903980

No of Pages : 79

Synopsis

Human platelet lysate (HPL) is a non-animal derived cell culture growth supplement obtained from blood platelets after freezing and thawing. HPL contains abundant growth factors and cytokines necessary for cell growth and proliferation. Platelet lysate can be used as a source of growth factors to replace bovine serum in cell culture medium. Replacing bovine serum with HPL allows expansion and clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens.

The global Human Platelet Lysate market was valued at US$ 2515 million in 2023 and is anticipated to reach US$ 2913.3 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Human Platelet Lysate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Platelet Lysate.

Report Scope

The Human Platelet Lysate market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Platelet Lysate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Platelet Lysate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Mill Creek Life Sciences
  • Merck & Co., Inc
  • STEMCELL Technologies Inc
  • AventaCell BioMedical
  • Compass Biomedical, Inc
  • Macopharma SA
  • Trinova Biochem GmbH
  • PL BioScience GmbH
  • Cook Regentec

Segment by Type

  • Heparin
  • Heparin Free

Segment by Application

  • Contract Research Organizations
  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Platelet Lysate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Platelet Lysate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Human Platelet Lysate Market Overview
1.1 Product Overview and Scope of Human Platelet Lysate
1.2 Human Platelet Lysate Segment by Type
1.2.1 Global Human Platelet Lysate Market Value Comparison by Type (2024-2030)
1.2.2 Heparin
1.2.3 Heparin Free
1.3 Human Platelet Lysate Segment by Application
1.3.1 Global Human Platelet Lysate Market Value by Application: (2024-2030)
1.3.2 Contract Research Organizations
1.3.3 Academic & Research Institutes
1.3.4 Pharmaceutical Companies
1.3.5 Others
1.4 Global Human Platelet Lysate Market Size Estimates and Forecasts
1.4.1 Global Human Platelet Lysate Revenue 2019-2030
1.4.2 Global Human Platelet Lysate Sales 2019-2030
1.4.3 Global Human Platelet Lysate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Platelet Lysate Market Competition by Manufacturers
2.1 Global Human Platelet Lysate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Platelet Lysate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Platelet Lysate Average Price by Manufacturers (2019-2024)
2.4 Global Human Platelet Lysate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Platelet Lysate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Platelet Lysate, Product Type & Application
2.7 Human Platelet Lysate Market Competitive Situation and Trends
2.7.1 Human Platelet Lysate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Platelet Lysate Players Market Share by Revenue
2.7.3 Global Human Platelet Lysate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Platelet Lysate Retrospective Market Scenario by Region
3.1 Global Human Platelet Lysate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Platelet Lysate Global Human Platelet Lysate Sales by Region: 2019-2030
3.2.1 Global Human Platelet Lysate Sales by Region: 2019-2024
3.2.2 Global Human Platelet Lysate Sales by Region: 2025-2030
3.3 Global Human Platelet Lysate Global Human Platelet Lysate Revenue by Region: 2019-2030
3.3.1 Global Human Platelet Lysate Revenue by Region: 2019-2024
3.3.2 Global Human Platelet Lysate Revenue by Region: 2025-2030
3.4 North America Human Platelet Lysate Market Facts & Figures by Country
3.4.1 North America Human Platelet Lysate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Platelet Lysate Sales by Country (2019-2030)
3.4.3 North America Human Platelet Lysate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Platelet Lysate Market Facts & Figures by Country
3.5.1 Europe Human Platelet Lysate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Platelet Lysate Sales by Country (2019-2030)
3.5.3 Europe Human Platelet Lysate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Platelet Lysate Market Facts & Figures by Country
3.6.1 Asia Pacific Human Platelet Lysate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Platelet Lysate Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Platelet Lysate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Platelet Lysate Market Facts & Figures by Country
3.7.1 Latin America Human Platelet Lysate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Platelet Lysate Sales by Country (2019-2030)
3.7.3 Latin America Human Platelet Lysate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Platelet Lysate Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Platelet Lysate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Platelet Lysate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Platelet Lysate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Platelet Lysate Sales by Type (2019-2030)
4.1.1 Global Human Platelet Lysate Sales by Type (2019-2024)
4.1.2 Global Human Platelet Lysate Sales by Type (2025-2030)
4.1.3 Global Human Platelet Lysate Sales Market Share by Type (2019-2030)
4.2 Global Human Platelet Lysate Revenue by Type (2019-2030)
4.2.1 Global Human Platelet Lysate Revenue by Type (2019-2024)
4.2.2 Global Human Platelet Lysate Revenue by Type (2025-2030)
4.2.3 Global Human Platelet Lysate Revenue Market Share by Type (2019-2030)
4.3 Global Human Platelet Lysate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Platelet Lysate Sales by Application (2019-2030)
5.1.1 Global Human Platelet Lysate Sales by Application (2019-2024)
5.1.2 Global Human Platelet Lysate Sales by Application (2025-2030)
5.1.3 Global Human Platelet Lysate Sales Market Share by Application (2019-2030)
5.2 Global Human Platelet Lysate Revenue by Application (2019-2030)
5.2.1 Global Human Platelet Lysate Revenue by Application (2019-2024)
5.2.2 Global Human Platelet Lysate Revenue by Application (2025-2030)
5.2.3 Global Human Platelet Lysate Revenue Market Share by Application (2019-2030)
5.3 Global Human Platelet Lysate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mill Creek Life Sciences
6.1.1 Mill Creek Life Sciences Corporation Information
6.1.2 Mill Creek Life Sciences Description and Business Overview
6.1.3 Mill Creek Life Sciences Human Platelet Lysate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mill Creek Life Sciences Human Platelet Lysate Product Portfolio
6.1.5 Mill Creek Life Sciences Recent Developments/Updates
6.2 Merck & Co., Inc
6.2.1 Merck & Co., Inc Corporation Information
6.2.2 Merck & Co., Inc Description and Business Overview
6.2.3 Merck & Co., Inc Human Platelet Lysate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck & Co., Inc Human Platelet Lysate Product Portfolio
6.2.5 Merck & Co., Inc Recent Developments/Updates
6.3 STEMCELL Technologies Inc
6.3.1 STEMCELL Technologies Inc Corporation Information
6.3.2 STEMCELL Technologies Inc Description and Business Overview
6.3.3 STEMCELL Technologies Inc Human Platelet Lysate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 STEMCELL Technologies Inc Human Platelet Lysate Product Portfolio
6.3.5 STEMCELL Technologies Inc Recent Developments/Updates
6.4 AventaCell BioMedical
6.4.1 AventaCell BioMedical Corporation Information
6.4.2 AventaCell BioMedical Description and Business Overview
6.4.3 AventaCell BioMedical Human Platelet Lysate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AventaCell BioMedical Human Platelet Lysate Product Portfolio
6.4.5 AventaCell BioMedical Recent Developments/Updates
6.5 Compass Biomedical, Inc
6.5.1 Compass Biomedical, Inc Corporation Information
6.5.2 Compass Biomedical, Inc Description and Business Overview
6.5.3 Compass Biomedical, Inc Human Platelet Lysate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Compass Biomedical, Inc Human Platelet Lysate Product Portfolio
6.5.5 Compass Biomedical, Inc Recent Developments/Updates
6.6 Macopharma SA
6.6.1 Macopharma SA Corporation Information
6.6.2 Macopharma SA Description and Business Overview
6.6.3 Macopharma SA Human Platelet Lysate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Macopharma SA Human Platelet Lysate Product Portfolio
6.6.5 Macopharma SA Recent Developments/Updates
6.7 Trinova Biochem GmbH
6.6.1 Trinova Biochem GmbH Corporation Information
6.6.2 Trinova Biochem GmbH Description and Business Overview
6.6.3 Trinova Biochem GmbH Human Platelet Lysate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Trinova Biochem GmbH Human Platelet Lysate Product Portfolio
6.7.5 Trinova Biochem GmbH Recent Developments/Updates
6.8 PL BioScience GmbH
6.8.1 PL BioScience GmbH Corporation Information
6.8.2 PL BioScience GmbH Description and Business Overview
6.8.3 PL BioScience GmbH Human Platelet Lysate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 PL BioScience GmbH Human Platelet Lysate Product Portfolio
6.8.5 PL BioScience GmbH Recent Developments/Updates
6.9 Cook Regentec
6.9.1 Cook Regentec Corporation Information
6.9.2 Cook Regentec Description and Business Overview
6.9.3 Cook Regentec Human Platelet Lysate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cook Regentec Human Platelet Lysate Product Portfolio
6.9.5 Cook Regentec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Platelet Lysate Industry Chain Analysis
7.2 Human Platelet Lysate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Platelet Lysate Production Mode & Process
7.4 Human Platelet Lysate Sales and Marketing
7.4.1 Human Platelet Lysate Sales Channels
7.4.2 Human Platelet Lysate Distributors
7.5 Human Platelet Lysate Customers
8 Human Platelet Lysate Market Dynamics
8.1 Human Platelet Lysate Industry Trends
8.2 Human Platelet Lysate Market Drivers
8.3 Human Platelet Lysate Market Challenges
8.4 Human Platelet Lysate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’